Pharma and biotech companies are scratching the surface when deploying artificial intelligence to streamline drug discovery and development.
InsightRX’s CEO and Co-founder, Sirj Goswami, PhD, as well as other experts, provide their thoughts on AI and its impact on drug discovery in this article from Drug Discovery & Development*.
Click here to read the Drug Discovery and Development article.
*About Drug Discovery & Development
Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation. We report on innovative drug introductions and promising pipeline candidates from Big Pharma and smaller players, as well as relevant clinical trial trends. The publication also covers promising technological developments relevant to the biotech, biopharma and pharma industries, including advances in artificial intelligence, genomic/proteomic sequencing and microscopy.
